Next-Gen Immuno-Oncology Conference

• Updates in development of ADC’s and Bispecific Ab’s
• Immune Checkpoint Inhibitors and Combinations
• Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators)
• Biomarkers and Personalized Medicine in IO
• CAR-T Cell therapy, TCR Based-Cell Therapy
• Tumor microenvironment and Oncolytic Viruses

CSO, Director, VP, Head, Senior Investigator, Manager, Principal Scientist, Team Leader, Group Leaders, Professors, Assistant Professors, Research fellows, PhDs working on

• Monoclonal and Bispecific Antibodies
• Cell Therapy
• Immune Checkpoint Inhibitors

• Exclusive conference to learn about antibodies, cellular therapy and immune-checkpoint research under one roof
• Find out new case studies of immune-oncology projects in development
• Contribute to interactive roundtables with your peers to deliberate key topics most relevant to you
• Explore the latest platforms and technologies on the market for development
• Discuss the best tool for your research in immune-oncology
• Share your work and achievements with your industry peers in the Poster Session